159 related articles for article (PubMed ID: 37310408)
21. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.
Wang S; Yu ZH; Chai KQ
Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194
[TBL] [Abstract][Full Text] [Related]
22. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
[TBL] [Abstract][Full Text] [Related]
23. High S100A7 expression is associated with early muscle invasion and poor survival in bladder carcinoma.
Dong Y; Zhu GY; Hao L; Liang Q; Zhou JH; Shi ZD; Yu H; Ma WM; Fan T; Zhang WD; Zang GH; Han CH
Ann Diagn Pathol; 2022 Feb; 56():151847. PubMed ID: 34742033
[TBL] [Abstract][Full Text] [Related]
24. Ceruloplasmin overexpression is associated with oncogenic pathways and poorer survival rates in clear-cell renal cell carcinoma.
Zhang Y; Chen Z; Chen JG; Chen XF; Gu DH; Liu ZM; Gao YD; Zheng B
FEBS Open Bio; 2021 Nov; 11(11):2988-3004. PubMed ID: 34449964
[TBL] [Abstract][Full Text] [Related]
25. TYROBP as a molecular target in cholangiocarcinoma, renal cancer and abdominal aortic aneurysm.
Jia W; Chen L; Hou S; Kang C; Deng H
Medicine (Baltimore); 2024 Jan; 103(1):e36843. PubMed ID: 38181271
[TBL] [Abstract][Full Text] [Related]
26. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
Yu Y; Cheng J; Mei CZ; Dai YZ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
[TBL] [Abstract][Full Text] [Related]
27. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
[TBL] [Abstract][Full Text] [Related]
28. Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
Li P; Cao J; Li J; Yao Z; Han D; Ying L; Wang Z; Tian J
Cancer Med; 2020 Oct; 9(19):7253-7267. PubMed ID: 32786144
[TBL] [Abstract][Full Text] [Related]
29. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
30. The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets.
Pang JS; Li ZK; Lin P; Wang XD; Chen G; Yan HB; Li SH
Oncol Rep; 2019 Apr; 41(4):2089-2102. PubMed ID: 30816528
[TBL] [Abstract][Full Text] [Related]
31. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Chen X; Liao L; Li Y; Huang H; Huang Q; Deng S
Biomed Res Int; 2020; 2020():7653506. PubMed ID: 33102593
[TBL] [Abstract][Full Text] [Related]
32. MYLK and CALD1 as molecular targets in bladder cancer.
Jin H; Liu B; Guo X; Qiao X; Jiao W; Yang L; Song X; Wei Y; Jin T
Medicine (Baltimore); 2023 Nov; 102(47):e36302. PubMed ID: 38013282
[TBL] [Abstract][Full Text] [Related]
33. Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma.
Jiao F; Sun H; Yang Q; Sun H; Wang Z; Liu M; Chen J
Int J Med Sci; 2020; 17(11):1610-1624. PubMed ID: 32669964
[TBL] [Abstract][Full Text] [Related]
34. KNTC1 and MCM2 are the molecular targets of gallbladder cancer.
Jia W; Wang C
Aging (Albany NY); 2023 Jul; 15(14):7008-7022. PubMed ID: 37480569
[TBL] [Abstract][Full Text] [Related]
35. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
36. Identification of biomarkers associated with progression and prognosis in bladder cancer via co-expression analysis.
Shi S; Tian B
Cancer Biomark; 2019; 24(2):183-193. PubMed ID: 30689556
[TBL] [Abstract][Full Text] [Related]
37. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis.
Zhang X; Yang L; Chen W; Kong M
Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291
[TBL] [Abstract][Full Text] [Related]
38. Characterization and function of biomarkers in sunitinib-resistant renal carcinoma cells.
Wang YL; Liu H; Wan LL; Pan KH; Ni JX; Hu Q; Bin X; Chen M
Gene; 2022 Jul; 832():146514. PubMed ID: 35550407
[TBL] [Abstract][Full Text] [Related]
39. Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer.
Zhang Z; Chai C; Shen T; Li X; Ji J; Li C; Shang Z; Niu Y
Dis Markers; 2019; 2019():4782730. PubMed ID: 31565099
[TBL] [Abstract][Full Text] [Related]
40. Identification and Analysis of Novel Biomarkers Involved in Chromophobe Renal Cell Carcinoma by Integrated Bioinformatics Analyses.
Zhang W; Xu Y; Zhang J; Wu J
Biomed Res Int; 2020; 2020():2671281. PubMed ID: 32090070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
